Opportunities and challenges of the new EU HTA regulation
The EU Health Technology Assessment Regulation (HTAR), approved in 2021, will become effective as of 12 January 2025. Its main objectives are to improve and speed up access for European patients to innovative health technologies —including both new medicines and medical devices— and to increase transparency and efficiency of the assessment processes. By establishing a
-> Continue reading Opportunities and challenges of the new EU HTA regulation